Pharmaceuticals
And now, USFDA bans imports from Sun Pharma unit
13 Mar 2014
The US regulator has been cracking down heavily on Indian generic pharmaceutical firms such as Ranbaxy and Wockhardt for alleged failure to comply with its manufacturing norms
GSK spends $1.05 bn to raise stake in Indian arm
11 Mar 2014
GlaxoSmithKline Plc (GSK) yesterday said that it has paid £625 million ($1.05 billion) to increase its stake in its Indian subsidiary GSK Pharmaceuticals to 75 per cent
Shocking dosage mix-up forces Ranbaxy to recall generic Liptor in US
08 Mar 2014
Quality concerns about India's $14 billion drug industry have come to the fore after the US FDA banned plants run by Ranbaxy and Wockhardt Ltd from sending drugs to the US, for failure to meet manufacturing standards
